Fosters Research
No Result
View All Result
No Result
View All Result
Fosters Research
No Result
View All Result
Home Industry

There’s Something Awry at SeaSpine Holdings Corporation (NASDAQ:SPNE) Since Share Price Gets Ahead of Fundamentals

January 9, 2023
in Industry

The stock of SeaSpine Holdings Corporation (NASDAQ:SPNE) last traded at $9.54, up 8.29% from the previous session.

SPNE stock price is now 34.71% away from the 50-day moving average and 27.76% away from the 200-day moving average. The market capitalization of the company currently stands at $360.18M.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

With the price target reduced from $12 to $6.75, Truist Downgraded its rating from Buy to Hold for SeaSpine Holdings Corporation (NASDAQ: SPNE). , while ‘Truist’ rates the stock as ‘Buy’.

In other news, Maniar Shweta, Director sold 3,786 shares of the company’s stock on Dec 29. The stock was sold for $30,288 at an average price of $8.00. Upon completion of the transaction, the Director now directly owns 23,993 shares in the company, valued at $0.23 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jul 14, President, Enabling Tech Standish Beau sold 50,000 shares of the business’s stock. A total of $286,500 was realized by selling the stock at an average price of $5.73. A total of 9.65% of the company’s stock is owned by insiders.

There have been several recent changes in the stakes of large investors in SPNE stock. In total, there are 148 active investors with 72.72% ownership of the company’s stock.

With an opening price of $8.83 on Friday morning, SeaSpine Holdings Corporation (NASDAQ: SPNE) set off the trading day. During the past 12 months, SeaSpine Holdings Corporation has had a low of $5.48 and a high of $14.23. The fifty day moving average price for SPNE is $7.27 and a two-hundred day moving average price translates $7.31 for the stock.

The latest earnings results from SeaSpine Holdings Corporation (NASDAQ: SPNE) was released for Jun, 2022. According to the Medical Devices Company, earnings per share came in at -$0.38, missing analysts’ expectations of -$0.35 by -0.03. This compares to -$0.48 EPS in the same period last year. The company reported revenue of $67.15 million for the quarter, compared to $46.45 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 44.57 percent. For the current quarter, analysts expect SPNE to generate $65.68M in revenue.

SeaSpine Holdings Corporation(SPNE) Company Profile

SeaSpine Holdings Corporation, a medical technology company, focuses on the design, development, and commercialization of surgical solutions for the treatment of spinal disorders in the United States and internationally. It offers orthobiologics and spinal implant solutions for the neurosurgeons and orthopedic spine surgeons to perform fusion procedures in the lumbar, thoracic, and cervical spine. The company’s orthobiologics products include demineralized bone matrix (DBM), collagen ceramic matrices, demineralized cancellous allograft bone products, and synthetic bone void fillers to improve bone fusion rates in a range of orthopedic surgeries, including spine, hip, and extremities procedures. It also offers orthobiologics products in various forms, such as fibers, putties, pastes, strips, and DBM. In addition, the company offers implant products for spinal decompression, alignment, stabilization, and image-guided surgical solutions, as well as a surgical navigation system used to facilitate fusion in degenerative, minimally invasive, and complex spinal deformity procedures throughout the lumbar, thoracic, and cervical regions of the spine. SeaSpine Holdings Corporation was incorporated in 2015 and is headquartered in Carlsbad, California.

Tags: NASDAQ:SPNESeaSpine Holdings CorporationSPNESPNE stock

Related Posts

Can Titan Pharmaceuticals Inc. (TTNP) stock recover despite sales dropping?

January 27, 2023

When is the right time to cash out of Matthews International Corporation [MATW] stock?

January 27, 2023

Investor Insight: OneWater Marine Inc. (ONEW) Goes Ballistic – Investor Confidence on the Rise

January 27, 2023

Is Atreca Inc. [BCEL] a good investment? Don’t be fooled by its recent momentum

January 27, 2023

The most important numbers to know about Ascent Solar Technologies Inc. (NASDAQ:ASTI)

January 27, 2023

Before You Invest In Harte Hanks Inc. (NASDAQ:HHS), Consider This Metric

January 27, 2023
Next Post

Do investors have a safe investment in Aligos Therapeutics Inc. (NASDAQ:ALGS)?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

There’s Something Awry at AngloGold Ashanti Limited (NYSE:AU) Since Share Price Gets Ahead of Fundamentals

2 months ago

A breakdown of the latest mutual funds holding IPG Photonics Corporation (IPGP)

3 months ago

TransMedics Group Inc. (TMDX) Price Aside, TMDX Fundamentals Booming Beyond Compare

3 months ago

What is Addex Therapeutics Ltd’s (NASDAQ:ADXN) current market value? Can you beat the fundamentals?

2 days ago
logo

Welcome to Fosters Research.
We provide quality information for free in a convenient place and format. You do not need to look for us – the news portal “Fosters Research” meets the reader every morning.

Categories

  • Analyst Opinions
  • Featured
  • Finance
  • Market News
  • Technical Indicators
  • Trending Stocks

Company

  • Home
  • About us
  • Contact

Recent Posts

  • Can Titan Pharmaceuticals Inc. (TTNP) stock recover despite sales dropping?
  • There is little time left for S&T Bancorp Inc. (STBA) to reach its 1-year target estimate. How soon will it surpass it?

Copyright © 2022 fostersresearch

No Result
View All Result
  • Home
  • Analyst Opinions
  • Market News
  • Technical Indicators
  • Trending Stocks

Copyright © 2022 fostersresearch